Multicenter Study of Phase II With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet), Vincristine, Prednisone, (R-COMP) in Non-Hodgkin's Lymphoma Diffuse Large B Cell in Cardiopathic Patients.
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2018
At a glance
- Drugs Cyclophosphamide (Primary) ; Doxorubicin (Primary) ; Prednisone (Primary) ; Rituximab (Primary) ; Vincristine (Primary)
- Indications Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Therapeutic Use
- Acronyms HEART01
- 01 Feb 2018 Results published in the Hematological Oncology
- 15 Jun 2014 Status changed from recruiting to completed, as per an abstract presented at the 19th Congress of the European Haematology Association
- 17 Mar 2012 Additional lead trial centre identified as reported by EudraCT.